Literature DB >> 24702964

Drug dealers, retaliation, and deterrence.

Scott Jacques1, Richard Wright2, Andrea Allen3.   

Abstract

BACKGROUND: Illicit drug sellers have limited access to formal mediation and therefore are rational targets to predators. As such, dealers are especially reliant on retaliation to deter victimization. Prior scholarship on dealers, retaliation, and deterrence has focused largely on general deterrence, or the effect of punishing one person on others. Research is yet to shed much light on other types of deterrence that dealers engage in.
METHODS: This paper addresses that gap by drawing on qualitative data obtained in interviews with 25 unincarcerated drug sellers from disadvantaged neighborhoods in St. Louis, Missouri.
RESULTS: We find that dealers' use of retaliation is linked to four kinds of deterrence-general, specific, situational, and permeating-and that these are combined into three forms: namely, specific-situational; specific-permeating; and comprehensive (i.e., all four kinds simultaneously).
CONCLUSION: Implications for research, theory, and "criminal justice" are discussed. Specifically, we call for future scholarship to examine how each type of deterrence affects the others, and suggest that both predation against and retaliation by drug dealers might be reduced by granting them greater access to formal means of dispute resolution.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Deterrence; Drug dealers; Offender decision-making; Retaliation

Mesh:

Year:  2014        PMID: 24702964     DOI: 10.1016/j.drugpo.2014.03.001

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  2 in total

1.  Trusting the source: The potential role of drug dealers in reducing drug-related harms via drug checking.

Authors:  Geoff Bardwell; Jade Boyd; Jaime Arredondo; Ryan McNeil; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2019-03-06       Impact factor: 4.492

2.  Effect of alternative income assistance schedules on drug use and drug-related harm: a randomised controlled trial.

Authors:  Lindsey Richardson; Allison Laing; JinCheol Choi; Ekaterina Nosova; M-J Milloy; Brandon Dl Marshall; Joel Singer; Evan Wood; Thomas Kerr
Journal:  Lancet Public Health       Date:  2021-04-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.